| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/02/2006 | WO2006021455A1 Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
| 03/02/2006 | WO2006021425A1 Sustained release pharmaceutical composition of tolterodine |
| 03/02/2006 | WO2006002365A3 Microparticles with high loadings of a bioactive agent |
| 03/02/2006 | WO2005123045A3 Controlled release matrix pharmaceutical dosage formulation |
| 03/02/2006 | WO2005107717A8 Oral dosage form for the extended release of biguanide and sulfonylurea |
| 03/02/2006 | WO2005105136A9 Nanogene therapy for cell proliferation disorders |
| 03/02/2006 | WO2005105072A3 Antifungal drug delivery |
| 03/02/2006 | WO2005105041A3 Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions |
| 03/02/2006 | WO2005094783A3 Serum-stable amphoteric liposomes |
| 03/02/2006 | WO2005086763A3 Stable injectable compositions |
| 03/02/2006 | WO2005072088A3 Immunotherapy compositions, method of making and method of use thereof |
| 03/02/2006 | WO2005058287A3 Transdermal delivery system of hormones without penetration enhancers |
| 03/02/2006 | WO2005048947A3 Oral delivery system and method for making same |
| 03/02/2006 | WO2005027843A3 Chronotherapeutic dosage forms |
| 03/02/2006 | WO2005013948A3 Method of treating acute myocardial infarction |
| 03/02/2006 | WO2005009407A3 Oral pharmaceutical formulations of olanzapine |
| 03/02/2006 | WO2004083379A3 Large volume ex vivo electroporation method |
| 03/02/2006 | WO2004069169A3 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 03/02/2006 | WO2004060278A3 Methods for rapid identification of pathogens in humans and animals |
| 03/02/2006 | WO2004032869A3 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 03/02/2006 | US20060047367 Method of controlling an implantable medical device with optimized pump drive |
| 03/02/2006 | US20060047270 Drug delivery apparatus and method for automatically reducing drug dosage |
| 03/02/2006 | US20060047263 Medical device and methods of use for glaucoma treatment |
| 03/02/2006 | US20060045917 Method of conveying matter into targeted cells in a human body |
| 03/02/2006 | US20060045916 Methods for producing silver nanoparticles |
| 03/02/2006 | US20060045915 Odor eliminating foot powder composition |
| 03/02/2006 | US20060045914 Matrix composition for stable microemulsions |
| 03/02/2006 | US20060045913 A bilayer tablet for the treating of nervous system disorders associated with serotonin deficiencies having a rapid-release layer of 5-hydroxytryptophan and a slow-release layer of tryptophan or 5-hydroxytryptophan; physiological conditions; side effect reduction |
| 03/02/2006 | US20060045912 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| 03/02/2006 | US20060045911 Stable pharmaceutical formulations |
| 03/02/2006 | US20060045910 Preserved fusogenic vesicles |
| 03/02/2006 | US20060045897 Occlusive articles for wart treatment |
| 03/02/2006 | US20060045891 Density-matched suspension vehicles and pharmaceutical suspensions |
| 03/02/2006 | US20060045851 Oral care composition comprising essential oils |
| 03/02/2006 | US20060045850 Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids |
| 03/02/2006 | US20060042650 Dental device with improved retention of a flavor and/or chemotherapeutic agent composition |
| 03/02/2006 | DE19916896B4 Teilchen mit kleiner Dimension, die eine Wand aus einem Gemisch von vernetzten Proteinen und Polysacchariden aufweisen, die an der Oberfläche mit Metallionen chelatbildende Hydroxamgruppen enthalten, Verfahren zu ihrer Herstellung und ihre verschiedenen Verwendungen insbesondere in der kosmetischen, pharmazeutischen und Nahrungsmittelindustrie Particles having smaller dimensions, which have a wall composed of a mixture of cross-linked proteins, and polysaccharides containing on the surface with metal ions chelating hydroxamic groups, process for their preparation and to their different uses, particularly in the cosmetic, pharmaceutical and food industry |
| 03/02/2006 | DE10297745T5 Pharmazeutische Zusammensetzung für ein System zur kontrollierten Arzneistoffabgabe A pharmaceutical composition for a system for the controlled drug delivery |
| 03/02/2006 | DE102004042139A1 Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit Oral dosage forms for obtaining a Retardierungseffektes after drug intake with a meal |
| 03/02/2006 | CA2803995A1 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 03/02/2006 | CA2578117A1 Treatment of posterior capsule opacification |
| 03/02/2006 | CA2578015A1 Crystalline maltitol powder less prone to consolidation and method for production thereof |
| 03/02/2006 | CA2577711A1 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 03/02/2006 | CA2577583A1 Controlled release nanoparticle active agent formulation dosage forms and methods |
| 03/02/2006 | CA2577432A1 Biodegradable diblock copolymers having reverse thermal gelation |
| 03/02/2006 | CA2577361A1 Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 03/02/2006 | CA2576552A1 Eye drops for the treatment of dry eye |
| 03/02/2006 | CA2576473A1 Liquid preparation of physiologically active peptide |
| 03/02/2006 | CA2575684A1 Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
| 03/02/2006 | CA2575499A1 Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
| 03/02/2006 | CA2575497A1 Improved stearate composition and method of production thereof |
| 03/02/2006 | CA2575407A1 Nanoparticles and method for the production thereof |
| 03/02/2006 | CA2574981A1 Compressed composite delivery system for release-rate modulation of bioactives |
| 03/02/2006 | CA2574463A1 Nanocoating for improving biocompatibility of medical implants |
| 03/02/2006 | CA2573612A1 Polyamino acids functionalised by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications |
| 03/02/2006 | CA2573151A1 Effervescent composition including a grape-derived component |
| 03/02/2006 | CA2553444A1 Rapidly disintegrating gelatinous coated tablets |
| 03/01/2006 | EP1629853A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 03/01/2006 | EP1629852A2 Topical anaesthesia formulation for bodily cavities |
| 03/01/2006 | EP1629846A2 Topical use of probiotic bacillus spores to prevent or control microbial infections |
| 03/01/2006 | EP1629844A1 A longterm delivery system with controlled initial burst |
| 03/01/2006 | EP1629842A1 Topical application of thiazolyl amides |
| 03/01/2006 | EP1629836A2 Method of growing crystals |
| 03/01/2006 | EP1629835A2 Breakable, controlled release device comprising a preformed passage |
| 03/01/2006 | EP1629834A1 Sustained release pharmaceutical composition of tolterodine |
| 03/01/2006 | EP1629833A1 Process for producing microparticle |
| 03/01/2006 | EP1629832A1 A pharmaceutical formulation comprising human growth hormone, an amino acid and a non-ionic detergent |
| 03/01/2006 | EP1629831A2 Vitreous humor tamponade and its use |
| 03/01/2006 | EP1629085A2 Transfection agents |
| 03/01/2006 | EP1628750A2 Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| 03/01/2006 | EP1628683A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 03/01/2006 | EP1628659A1 Use of poly-aminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 03/01/2006 | EP1628655A2 Antiseptic compositions, methods and systems |
| 03/01/2006 | EP1628648A1 Deramciclane-fumarate tablets |
| 03/01/2006 | EP1628645A1 Stabilized aerosol dispersions |
| 03/01/2006 | EP1628644A1 Nanocomposite drug delivery composition |
| 03/01/2006 | EP1628643A2 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 03/01/2006 | EP1628642A1 Controlled drug release composition resistant to in vivo mechanic stress |
| 03/01/2006 | EP1628641A2 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 03/01/2006 | EP1628640A2 Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer |
| 03/01/2006 | EP1628639A2 Antimicrobial quaternary ammonium organosilane coatings |
| 03/01/2006 | EP1628638A2 Antibiotic composition |
| 03/01/2006 | EP1628637A2 Method of pulmonary administration of an agent |
| 03/01/2006 | EP1628636A1 Injectable liposomal depots for delivering active ingredients |
| 03/01/2006 | EP1628635A2 Stabilized particle dispersions containing nanoparticles |
| 03/01/2006 | EP1628634A1 Novel lipid mixtures for synthetic surfactants |
| 03/01/2006 | EP1628633A1 Improvements in adhesives and their applications |
| 03/01/2006 | EP1628624A2 Methods and compositions for interferon therapy |
| 03/01/2006 | EP1628620A2 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom |
| 03/01/2006 | EP1628529A2 Inducible release vehicles |
| 03/01/2006 | EP1551417A4 Three layer tear formulation |
| 03/01/2006 | EP1503753A4 A method for inhibiting platelet aggregation |
| 03/01/2006 | EP1455774B1 Pharmaceutical composition for treating obesity |
| 03/01/2006 | EP1453523B1 Heparin-containing ophthalmic agent |
| 03/01/2006 | EP1446119B1 Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| 03/01/2006 | EP1438023B1 Process for preparing crystalline particles of fluticasone, beclomethasone, salmeterol and salbutamol |
| 03/01/2006 | EP1430059B1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 03/01/2006 | EP1408768B1 SUGAR-FREE HARD COATINGS PREPARED FROM LIQUID MALTITOL COMPRISING DP sb 4+ /sb FRACTION |
| 03/01/2006 | EP1379203B1 Condom with an erectogenic composition |
| 03/01/2006 | EP1352654B1 Famotidine injections |